Literature DB >> 15718836

Different subsets of peripheral blood dendritic cells show distinct phenotypic and functional abnormalities in HIV-1 infection.

María Almeida1, Miguel Cordero, Julia Almeida, Alberto Orfao.   

Abstract

OBJECTIVES: To analyse the distribution, expression of chemokine receptors and ex vivo production of inflammatory cytokines by peripheral blood (PB) monocytes and DC in HIV-1+ individuals.
DESIGN: Dendritic cells (DC) play an important role in the establishment and dissemination of HIV infection. DC interaction with HIV depends on expression of HIV receptors and co-receptors. Accumulating evidence supports the notion that DC functionality is impaired in HIV-1+ patients.
METHODS: PB samples from 30 naive-treated HIV-1+ progressors were studied. Additionally, 10 adult healthy volunteers (AHV), seven Hepatitis C virus positive (HCV+)/HIV-1- patients and five long-term non-progressor HIV-1+ patients (HIV-1+LTNP) were included as controls. Flow cytometry immunophenotyping was used for the identification, enumeration and characterization of monocytes and DC.
RESULTS: PB myeloid DC (mDC) and plasmacytoid DC (pDC) were significantly decreased in HIV-1+ progressors, while unaltered in HIV-1+LTNP. The expression of CXCR2 and CXCR4 and of CXCR4 and CCR5 were severely altered on PB mDC and pDC from HIV-1+ progressors, respectively. By contrast, both the expression of the chemokine receptors analysed and the numbers of CD16+ DC in HIV-1+ progressors were not different from AHV, while altered in HCV+/HIV-1- and HIV-1+LTNP. Furthermore, PB monocytes and DC from HIV-1+ progressors spontaneously produced inflammatory cytokines, in contrast with AHV.
CONCLUSIONS: These results support the existence of a selective interaction between HIV-1 and both mDC and pDC, associated with HCV co-infection-independent spontaneous production of inflammatory cytokines, reflecting the occurrence of in vivo activation of the immune system, which might further contribute to the impaired DC functionality.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15718836

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  50 in total

1.  Accumulation of functionally immature myeloid dendritic cells in lymph nodes of rhesus macaques with acute pathogenic simian immunodeficiency virus infection.

Authors:  Viskam Wijewardana; Anthea L Bouwer; Kevin N Brown; Xiangdong Liu; Simon M Barratt-Boyes
Journal:  Immunology       Date:  2014-10       Impact factor: 7.397

2.  Effect of Chronic Uremia on the Cell Surface Expression of B7 Family Costimulatory Molecules in an HLA-A2 Transgenic Mouse Model of Chronic Kidney Disease.

Authors:  Paul E Makidon; Douglas M Smith; Jeffery V Groom Ii; Zhengyi Cao; Jeffery J Landers; James R Baker
Journal:  Comp Med       Date:  2015-08       Impact factor: 0.982

3.  HIV type 1 infection up-regulates TLR2 and TLR4 expression and function in vivo and in vitro.

Authors:  Juan C Hernández; Mario Stevenson; Eicke Latz; Silvio Urcuqui-Inchima
Journal:  AIDS Res Hum Retroviruses       Date:  2012-03-12       Impact factor: 2.205

4.  Variations in plasmacytoid dendritic cell (PDC) and myeloid dendritic cell (MDC) levels in HIV-infected subjects on and off antiretroviral therapy.

Authors:  Barbara Schmidt; Sue H Fujimura; Jeffrey N Martin; Jay A Levy
Journal:  J Clin Immunol       Date:  2006-01       Impact factor: 8.317

5.  HIV-1 matrix protein p17 induces human plasmacytoid dendritic cells to acquire a migratory immature cell phenotype.

Authors:  Simona Fiorentini; Elena Riboldi; Fabio Facchetti; Manuela Avolio; Marco Fabbri; Giorgio Tosti; Pablo D Becker; Carlos A Guzman; Silvano Sozzani; Arnaldo Caruso
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-29       Impact factor: 11.205

6.  Plasma factors during chronic HIV-1 infection impair IL-12 secretion by myeloid dendritic cells via a virus-independent pathway.

Authors:  Elizabeth A Miller; Meredith R Spadaccia; Meagan P OʼBrien; Linda Rolnitzky; Rachel Sabado; Olivier Manches; Davor Frleta; Nina Bhardwaj
Journal:  J Acquir Immune Defic Syndr       Date:  2012-12-15       Impact factor: 3.731

7.  HIV turns plasmacytoid dendritic cells (pDC) into TRAIL-expressing killer pDC and down-regulates HIV coreceptors by Toll-like receptor 7-induced IFN-alpha.

Authors:  Andrew W Hardy; David R Graham; Gene M Shearer; Jean-Philippe Herbeuval
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-23       Impact factor: 11.205

8.  Plasmacytoid dendritic cells accumulate and secrete interferon alpha in lymph nodes of HIV-1 patients.

Authors:  Clara Lehmann; Mark Lafferty; Alfredo Garzino-Demo; Norma Jung; Pia Hartmann; Gerd Fätkenheuer; Jeffrey S Wolf; Jan van Lunzen; Fabio Romerio
Journal:  PLoS One       Date:  2010-06-14       Impact factor: 3.240

9.  Semi mature blood dendritic cells exist in patients with ductal pancreatic adenocarcinoma owing to inflammatory factors released from the tumor.

Authors:  Vegard Tjomsland; Anna Spångeus; Per Sandström; Kurt Borch; Davorka Messmer; Marie Larsson
Journal:  PLoS One       Date:  2010-10-15       Impact factor: 3.240

10.  Chloroquine modulates HIV-1-induced plasmacytoid dendritic cell alpha interferon: implication for T-cell activation.

Authors:  Jeffrey A Martinson; Carlos J Montoya; Xiomara Usuga; Rollie Ronquillo; Alan L Landay; Seema N Desai
Journal:  Antimicrob Agents Chemother       Date:  2009-11-30       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.